EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Genetic Variation in Response to the Mediterranean–DASH Intervention for Neurodegenerative Delay (MIND): A Randomized Controlled Trial

Marilyn C Cornelis iD, Lisa L Barnes iD

Nutrients · 2026

DOI: 10.3390/nu18030508 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2026. Verfasst von Marilyn C Cornelis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. Hauptthemen laut MEDLINE: Catechol O-Methyltransferase, Diet, Mediterranean, Alzheimer Disease, Genetic Variation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Mediterranean–DASH Intervention for Neurodegenerative Delay (MIND) study was a 3-year randomized controlled trial to test the effects of the MIND diet on cognitive decline in individuals at risk for Alzheimer’s dementia (AD). Here we examine whether genetic differences in (a) AD predisposition and (b) nutrient metabolism modify the effect of MIND on cognitive change.

Methods

This secondary analysis included 494 trial participants of genetically inferred European ancestry with genetic data. Genetic scores (GS) were derived from prior genome-wide studies of AD and nutrient biomarkers. Linear regression and linear mixed models were used to examine the main effects of GS and interactions with diet assignment on cognition. An exploratory genome-wide interaction analysis was also performed.

Results

We observed a statistically significant interaction (p = 0.002) between the COMT Val158Met variant and diet assignment for the 3-year change in perceptual speed. Met/Met (lower enzyme activity) carriers’ perceptual speed improved more on the MIND than the control diet, while no difference by diet was observed for Val carriers.

Conclusions

Catechol-O-methyltransferase (COMT) metabolizes catecholamines as well as polyphenols unique to the MIND diet. Individuals with genetically impaired COMT activity may be especially responsive to the cognitive benefits of the MIND diet.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Catechol O-MethyltransferaseDiet, MediterraneanAlzheimer DiseaseGenetic VariationNeurodegenerative DiseasesHumansFemaleMaleAgedCognitionMiddle AgedGenetic Predisposition to DiseaseCognitive Enhancement

Stichwörter der Autor:innen

clinical trialcognitive declinedementiadiet patterngenotype

Substanzen

Catechol O-MethyltransferaseCOMT protein, human

Autor:innen und Institutionen

  • Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
  • Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA.
  • Rush Alzheimer's Disease Center, Chicago, IL 60612, USA.

ORCID-Profile: Marilyn C Cornelis, Lisa L Barnes

Förderung

  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Cornelis, M. C., & Barnes, L. L. (2026). Genetic Variation in Response to the Mediterranean–DASH Intervention for Neurodegenerative Delay (MIND): A Randomized Controlled Trial. Nutrients. https://doi.org/10.3390/nu18030508

Vancouver

Cornelis MC, Barnes LL. Genetic Variation in Response to the Mediterranean–DASH Intervention for Neurodegenerative Delay (MIND): A Randomized Controlled Trial. Nutrients. 2026. doi:10.3390/nu18030508

BibTeX
@article{Cornelis2026,
  author = {Cornelis, Marilyn C and Barnes, Lisa L},
  title = {Genetic Variation in Response to the Mediterranean–DASH Intervention for Neurodegenerative Delay (MIND): A Randomized Controlled Trial},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18030508}
}
Kostenlos starten →